Network based biomarkers in Alzheimer's disease: review and future directions

Network based biomarkers in Alzheimer's disease: review and future directions

By 2050 it is estimated that the number of worldwide Alzheimer’s (AD) patients will quadruple from the current number of 36 million people. To date, no single test, prior to postmortem examination, can confirm that a person suffers from AD. Therefore, there is a strong need for accurate and sensitiv...

Full description

Bibliographic Details
Main Authors:	Jaime eGomez-Ramirez, Jinglong eWu
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2014-02-01
Series:	Frontiers in Aging Neuroscience
Subjects:	Default Mode Network positron emission tomography (PET) amyloid-beta peptide Bayesian inference Model selection AD
Online Access:	http://journal.frontiersin.org/Journal/10.3389/fnagi.2014.00012/full

Similar Items

Does inflammation precede tau aggregation in early Alzheimer's disease? A PET study
by: Peter Parbo, et al.
Published: (2018-09-01)

Plasma amyloid beta levels are associated with cerebral amyloid and tau deposition
by: Shannon L. Risacher, et al.
Published: (2019-12-01)

Alzheimer’s Biomarkers are Correlated with Brain Connectivity in Older Adults Differentially during Resting and Task States
by: Yang eJiang, et al.
Published: (2016-02-01)

Effects of Alzheimer’s and Vascular Pathologies on Structural Connectivity in Early- and Late-Onset Alzheimer’s Disease
by: Wha Jin Lee, et al.
Published: (2021-02-01)

Alzheimer’s cerebrospinal biomarkers from Lumipulse fully automated immunoassay: concordance with amyloid-beta PET and manual immunoassay in Koreans
by: Sohee Moon, et al.
Published: (2021-01-01)

Cross‐sectional and longitudinal atrophy is preferentially associated with tau rather than amyloid β positron emission tomography pathology
by: Brian A. Gordon, et al.
Published: (2018-01-01)

Clinical Implications of Amyloid-Beta Accumulation in Occipital Lobes in Alzheimer’s Continuum
by: Jihye Hwang, et al.
Published: (2021-09-01)

Beta-amyloid imaging in dementia
by: Kyung Ah Chun
Published: (2018-06-01)

Correlating Neuropsychiatric Symptoms with Regional Beta-Amyloid Load in the Alzheimer’s Disease Brain Using [11C]SB-13 Positron Emission Tomography
by: Kaye, Edward David
Published: (2010)

Correlating Neuropsychiatric Symptoms with Regional Beta-Amyloid Load in the Alzheimer’s Disease Brain Using [11C]SB-13 Positron Emission Tomography
by: Kaye, Edward David
Published: (2010)

Absence of Relationship Between Self-Reported Sleep Measures and Amyloid Load in Elderly Subjects
by: Audrey Gabelle, et al.
Published: (2019-09-01)

Characterization of [18F]flutemetamol binding properties : A β-amyloid PET imaging ligand
by: Heurling, Kerstin
Published: (2015)

Fluid biomarkers in clinical trials of Alzheimer’s disease therapeutics
by: Aaron eRitter, et al.
Published: (2015-08-01)

Membranes biomimétiques pour la caractérisation de nouveaux agents thérapeutiques : application à la maladie d'Alzheimer
by: Smeralda, Willy
Published: (2019)

A biomarker study in long-lasting amnestic mild cognitive impairment
by: Chiara Cerami, et al.
Published: (2018-04-01)

Mechanisms of nerve cell death in Down's syndrome and Alzheimer's disease
by: Williamson, Ritchie
Published: (2001)

Comparison of Cerebrospinal Fluid Amyloidogenic Nanoplaques With Core Biomarkers of Alzheimer’s Disease
by: Mari Aksnes, et al.
Published: (2021-01-01)

Resting-state functional connectivity and amyloid burden influence longitudinal cortical thinning in the default mode network in preclinical Alzheimer’s disease
by: Olivia L. Hampton, et al.
Published: (2020-01-01)

Role of the N-Terminal Hydrophilic Region of Amyloid Beta Peptide in Amyloidogenesis, Membrane Interaction and Toxicity Associated with Alzheimer’s Disease

Cross-sectional associations of plasma vitamin D with cerebral β-amyloid in older adults at risk of dementia
by: Fati Nourhashemi, et al.
Published: (2018-04-01)

Preparation of 18F-Labeled Styryl Nitrogenous Heterocycles
by: LIU Yinli1;LI Zhongyong1,2
Published: (2018-02-01)

PET and the Multitracer Concept: An Approach to Neuroimaging Pathology
by: Engler, Henry
Published: (2008)

Fluorinated Molecules and Nanotechnology: Future ‘Avengers’ against the Alzheimer’s Disease?
by: Meghna Dabur, et al.
Published: (2020-04-01)

The Prior Can Often Only Be Understood in the Context of the Likelihood
by: Andrew Gelman, et al.
Published: (2017-10-01)

Comparison of multiple tau-PET measures as biomarkers in aging and Alzheimer's disease
by: Anne Maass, et al.
Published: (2017-08-01)

18F-Florbetaben Amyloid PET Imaging: A Chinese Study in Cognitive Normal Controls, Mild Cognitive Impairment, and Alzheimer’s Disease Patients
by: Yan Chang, et al.
Published: (2020-07-01)

Longitudinal Assessment of Amyloid-β Deposition by [18F]-Flutemetamol PET Imaging Compared With [11C]-PIB Across the Spectrum of Alzheimer’s Disease
by: Shizuo Hatashita, et al.
Published: (2019-09-01)

The Relation Between Brain Amyloid Deposition, Cortical Atrophy, and Plasma Biomarkers in Amnesic Mild Cognitive Impairment and Alzheimer’s Disease
by: Ling-Yun Fan, et al.
Published: (2018-06-01)

Brain injury, neuroinflammation and Alzheimer’s disease
by: Joshua eBreunig, et al.
Published: (2013-07-01)

Cerebrospinal fluid and plasma biomarker trajectories with increasing amyloid deposition in Alzheimer's disease
by: Sebastian Palmqvist, et al.
Published: (2019-12-01)

Neuroimaging assessment of early and late neurobiological sequelae of traumatic brain injury: implications for CTE
by: Mark eSundman, et al.
Published: (2015-09-01)

Diagnostic biomarkers in Alzheimer’s disease
by: Emerlee Andersen, et al.
Published: (2021-12-01)

Topographical distribution of Aβ predicts progression to dementia in Aβ positive mild cognitive impairment
by: Tharick A. Pascoal, et al.
Published: (2020-01-01)

Regional hypometabolism in the 3xTg mouse model of Alzheimer's disease
by: Aida Adlimoghaddam, et al.
Published: (2019-07-01)

Associations of quantitative susceptibility mapping with Alzheimer's disease clinical and imaging markers
by: Petrice M. Cogswell, et al.
Published: (2021-01-01)

Comparison of amyloid PET measured in Centiloid units with neuropathological findings in Alzheimer’s disease
by: Sanka Amadoru, et al.
Published: (2020-03-01)

Functionalization of stable fluorescent nanodiamonds towards reliable detection of biomarkers for Alzheimer’s disease
by: Francisco Morales-Zavala, et al.
Published: (2018-08-01)

Protein Biomarkers for the Diagnosis of Alzheimer’s Disease at Different Stages of Neurodegeneration
by: Mar Pérez, et al.
Published: (2020-09-01)

A systematic review and meta‐analysis of 18F‐labeled amyloid imaging in Alzheimer's disease
by: Jing Ming Yeo, et al.
Published: (2015-03-01)

Focused ultrasound and Alzheimer’s disease A systematic review
by: Rodrigo Marmo da Costa e Souza, et al.